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Abstract 
Placenta is the major exchange surface between mother and fetus and plays a pivotal role in fetal development. A 
better understanding of the mechanisms by which diabetes alters placental function may allow better management 
of diabetes pregnancies. In this study, we attempt to investigate the effect of diabetic milieu with and without malfor-
mation on placental function. In order to investigate the impact of diabetic pregnancy on oxidative stress, endothelial 
and vascular functions of placental tissue, we mated diabetic and non-diabetic female rats with normal male rats. At 
gestational day 17, we terminated pregnancy, assessed fetuses for malformations and isolated placenta for measure-
ment of various parameters of placental function. Our results show that maternal diabetes induced a state of oxida-
tive stress in placenta, which disrupts normal signaling, activating apoptosis, as well as perturbing endothelial and 
vascular placental functions. The coalescence of these insults on various levels of placental function could contribute 
to the pleiotropic nature of diabetes-induced placental stress.
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Background
Placenta is an evolutionary conserved organ present in 
almost all female mammal pregnancies (Wildman 2011). 
Placenta is essential for consummate pregnancy, and 
serves several roles including: secretion of hormones, 
interface to allow exchange of metabolites, oxygen and 
nutrients between maternal and fetal circulation, as 
well as modulating maternal immune system and fetal 
growth (John and Hemberger 2012). Placentogenesis is 
initiated early during mammalian pregnancy due to dif-
ferentiation of trophoblasts from early embryonic stem 
cells. Nevertheless, complete layers of rats’ placenta are 
discerned from as early as gestational day (GD) 12 (De 
Rijk et al. 2002). Placental function increases during the 
late phase of pregnancy to compensate for the increase 
in fetal circulation (De Rijk et al. 2002). Therefore, GD 17 
was chosen to assess placental function in its peak and 
to decrease confounding factors such as normal increase 
in placenta oxidative stress that occurs in later days of 
gestation.
Placenta secretes several growth factors including 
placenta growth factor (PIGF2), which promotes pro-
liferation of placental vasculature and has an affinity to 
vascular endothelial growth factor (VEGF) receptors 
(Hauser and Weich 1993). PlGF-2 is a growth factor 
isoform that is secreted exclusively by umbilical cord 
endothelial cells and placenta (Hauser and Weich 1993). 
Soluble VEGF receptor1 (sVEGFR1) or soluble fms-like 
tyrosine kinase-1 (sFlt-1) is a splice variant of VEGFR1 
and act as receptor for PIGF-2 expressed on endothelial 
cells and have several anti-angiogenic functions through 
several mechanisms (Wu et al. 2010).
Diabetes and/or hyperglycemia during pregnancy per-
turbs placental and fetal development (Castori 2013); 
however, the mechanism and contribution of defects 
introduced by diabetic milieu on placenta is not well 
established. Diabetes-induced embryopathy and malfor-
mations were established since early twentieth century 
(Castori 2013). The abnormal milieu instigated by dia-
betes and/or abnormal placental function may disturb 
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the fetus on short term, but also may contribute to the 
development of disease later on in life (fetal origins of 
disease) (Calkins and Devaskar 2011). In order to bet-
ter control and manage diabetic pregnancies to reduce 
embryopathies and possible adult effects, we need deeper 
understanding of the cellular and molecular mechanisms 
underlying diabetic sabotage of fetal development. Basic 
research using animal models has contributed a consid-
erable amount of information about the manifestations of 
fetal abnormalities, but the effect of diabetes on placenta 
has not been thoroughly investigated.
Several cellular mechanisms contribute to the pathol-
ogy of diabetic malformations including impaired 
endothelial function, increased apoptosis, and oxida-
tive stress that disrupt organelle function as well as pro-
tein folding and processing (Gareskog et al. 2007). These 
apoptotic activities are mediated by increased expression 
and activity of cleaved caspase-3, which is regulated by 
high caspase-8 activity under hyperglycemic conditions 
(Yang et  al. 2008). Moreover, hyperglycemia alters nor-
mal placental function by reducing expression of VEGF-
A, VEGFR-1/Flt-1 and PIGF in placenta and serum of 
diabetic mothers. These perturbations might mediate the 
negative effects of diabetes on placental vasculature (Hel-
ske et al. 2001).
Hyperglycemia induces oxidative stress mainly through 
increased flux of NADH and FADH2 to electron trans-
port chain that promote mitochondrial dysregulation and 
generation of superoxide radicals (Saad et al. 2015). Also, 
it impairs intracellular antioxidant defense by decreas-
ing levels of reduced glutathione (GSH) and increasing 
oxidized glutathione (GSSG). Since glutathione system, 
the predominant intracellular antioxidant mechanism, 
is impaired and reactive oxygen species (ROS) produc-
tion is increased; this imbalance induces a state of oxida-
tive stress, which disrupts normal cellular signaling and 
leads to metabolic adverse effects of diabetic pregnancy 
(Sakamaki et al. 1999). Although ROS is involved in sev-
eral physiological functions, the term of oxidative stress is 
reserved mainly for the pathological mechanism or effects 
(Sies 2015). One major direct effect of oxidative stress is 
oxidation of nitric oxide—a critical vasodilator and signal-
ing molecule in early development—by reacting with ROS 
to form nitroperoxides, which in turn induce nitrosative 
stress. A proxy for nitrosative stress that may reflect levels 
of protein nitrosylation is nitrous and nitric oxides levels 
in tissues, collectively known as nitric oxide end products 
(NOx) (Jawerbaum et  al. 2005). 8-Oxo-7,8-dihydro-2′-
deoxyguanosine (8-oxo-dG) is a major biomarker of DNA 
damage induced by oxidative stress. It is formed by the 
reaction of OH radical with the DNA guanine base and 
usually result in point mutations (Cooke and Evans 2007a).
Cyclooxygenase enzymes COX-1 and COX-2 convert 
arachidonic acid into prostaglandins such as prostaglan-
din E2 (PGE2), while free radicals convert arachidonic 
acid into PGE2-like isoprostanes. In embryos of diabetic 
pregnancy, COX-2 activity and expression are reduced, 
which decrease PGE2 significantly and shift arachidonic 
acid metabolism into production of PGE2-like isopros-
tanes by ROS (El-Bassiouni et  al. 2005). PGE2 protect 
embryos from the damages due to hyperglycemic con-
ditions (Goto et  al. 1992), while PGE2-like isoprostanes 
have damaging effects in animal models of diabetic preg-
nancy and embryos exposed to high glucose in culture 
(Wentzel and Eriksson 2002).
In this study, we investigate the impact of diabetic 
milieu on placental function of malformed and non-
malformed fetuses, to study the effect of diabetes with 
and without malformations on placental function in late 
gestation. We assessed the impact of maternal diabetes 
through several parameters of vascular and oxidative pro-
cesses in placenta. Our hypothesis is that diabetes affects 




The animal protocol was approved by the Institu-
tional Animal Care and Use Committee at the Medi-
cal Research Institute—Alexandria University. Thirty 
female Local Wistar-derived strain rats were included 
in the experiment and had an initial average weight of 
180 ±  20  g. Rats were given tap water and commercial 
pellet diet ad  libitum. Animals were housed individu-
ally on a 12-h light/dark cycle and were kept at constant 
humidity and temperature (20 ± 5 °C).
Induction of experimental diabetes
Diabetes was induced in adult female rats group (n = 15) 
through intraperitoneal injection of 55  mg/kg Strep-
tozotocin (STZ; Sigma-Aldrich Chemical Co., Poole, 
UK) dissolved in sodium citrate buffer (0.01 M, pH 4.5) 
given daily over two successive days. An equivalent vol-
ume of buffer was administered to the control group 
(n = 15). Glucometer (Elite) was used for measuring glu-
cose levels. Diabetes was confirmed by a blood glucose 
level >11  mmol/l measured 1  week after Streptozotocin 
injections.
Mating
Female rats of both groups were mated with healthy non-
diabetic males overnight. The presence of sperm mucus 
plug in the vagina the following morning signified preg-
nancy (GD 0).
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Sample collection and preparation
Female rats of both groups were culled by cervical dislo-
cation on GD 17. In each sacrificed rat, the uterus was 
exposed by cesarean section and the number of implan-
tations and resorptions were noted. The live embryos 
and their placentae were dissected out of the uterine 
horns, rinsed carefully in phosphate buffered saline 
(PBS). Overall growth and differentiation of the embryos 
were quantified by direct measurement of crown-to-
rump length (CRL). The embryos were examined with 
regard to general morphology, and embryo and placen-
tae were weighed. The occurrence of disturbed embry-
onic development was noted such as open neural tube, 
growth retardation and appearance of specific organs 
(head, ear, heart, legs, tail, and body rotation). Embryos 
were denoted as “malformed” if one or more of these 
structures exhibited an apparent anomaly. The weights 
of embryos and placentae were recorded. The placentae 
were snap-frozen in liquid nitrogen for subsequent anal-
ysis. Placenta was homogenized in 3  mL of 0.1  M Tris-
HCl buffer, pH 7.4 containing 1  mM EDTA. Then the 
homogenates were centrifuged at 10,000g for 15  min at 
4 °C. The supernatant was removed and stored at −80 °C 
for subsequent assays.
Sample assays
COX enzymes activity assays were determined according 
to the procedure used by Kargman et al. (1996). Briefly, 
the activity of COX-1 was assessed in the standard and 
placental (control and diabetic) supernatants treated 
with COX-2 inhibitor, and compared with the activ-
ity of a mixture of both standard COX-1 and placental 
supernatant treated with COX-2 inhibitor. The kit (Cay-
man Chemical Company; Ann Arbor, MI, USA) includes 
isozyme-specific inhibitors for distinguishing COX-2 
from COX-1 activity.
The concentration of PlGF-2 was determined quan-
titatively using EIA kit (R & D systems, Inc., Minne-
apolis, MN, USA) with a sensitivity of 8.38  pg/mL. The 
intra- and inter-assay coefficients of variation were 8 and 
13 %, respectively. Placenta level of sVEGFR1/sFlt-1 was 
determined by competitive ELISA kit (Kamiya Biomedi-
cal Company, Seattle, WA, USA) according to manufac-
turer instructions. Caspase-3 activity was assayed by a 
method described by Thornberry (1994). Briefly, a fluo-
rescently labeled substrate for caspase 3 was added and 
the rate of its degradation was assessed by ELISA. Oxida-
tive stress parameters measured included thiobarbituric 
acid reactive substances (TBARS), which represents lipid 
peroxidation end-products and quantified as malondial-
dehyde (MDA). TBARS was assayed by a protocol devel-
oped by Draper and Hadley (1990). Briefly, this involves 
the reaction between thiobarbituric acid and MDA, 
which gives off a colored product assayed by colorimetry. 
While glutathione oxidation parameters were assayed 
by an enzymatic recycling assay developed by Griffith 
(1980). Shortly, GSH is oxidized by 5,5′-dithio-bis(2-
nitrobenzoic acid) (DNTB) to from a product detected by 
colorimetry. Total glutathione level is detected by reduc-
ing all the GSSG resulting from the previous reaction 
using (NADPH and glutathione reductase) and repeat-
ing the initial assay again. Tissue content of vitamin C 
was assayed by colorimetry using Folin phenol reagent 
(Jagota and Dani 1982), vitamin E using HPLC (McCor-
mick and Green 1996) and selenium by atomic absorp-
tion spectroscopy (AAS) (Herber and Stoeppler 1994) 
were also assayed in the placentae of all study groups. 
Protein content was determined using a modification of 
the method of Lowry et al. (1951). The specific activity of 
each enzyme was determined by dividing its activity by 
the protein concentration in the sample (U/mg protein).
Isolated DNA was washed twice with 70  % etha-
nol, dried, and dissolved in 200  μl of 10  mM Tris/HCl, 
0.1  mM EDTA and 100  mM NaCl (pH 7.0). For enzy-
matic digestion, 100 units of DNase I were added per 
200 μg DNA at 37  °C for 1 h. Then, 5 units of nuclease 
P1 and 30 μl of 10 mM ZnSO4 were added, and the mix-
ture was incubated for 1  h. After re-adjusting the pH 
with 100 μl of 0.4 M Tris/HCl (pH 7.8) followed by the 
addition of three units alkaline phosphatase, the samples 
were incubated for 30  min. Enzymes were precipitated 
with acetone (5 vol), removed by centrifugation, and the 
supernatant was evaporated to dryness. The DNA hydro-
lysates were evaluated for 8-oxo-dG content using HT 
8-oxo-dG ELISA Kit II (Trevigen, USA).
The nitrite and nitrate (NOx) concentration was deter-
mined by simple Griess reaction (Guevara et  al. 1998). 
Briefly the assay consists of two steps: diazotization of 
sulphanilic acid with nitrite ion and coupling of this 
product with diamine, which results in a measurable pink 
metabolite that measured at 540 nm. Before diazotization 
reaction, all nitrate ions present in tissue were converted 
to nitrite ions by the action of NADPH-dependent nitrate 
reductase.
Statistical analysis
All data are presented as mean ± SD. A one-way analysis 
of variance (ANOVA) with post hoc test (LSD) was per-
formed on each normally distributed variable to compare 
the mean values. Differences were considered significant 
at P  <  0.05. For pregnancy outcome, results were ana-
lyzed by Fisher’s exact test. All statistical analyses were 
performed using SPSS statistical software version 18 
(SPSS, Chicago, IL, USA).
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Results
In this study, we investigated several parameters of oxida-
tive stress, endothelial function, angiogenesis and apop-
tosis to get a better understanding of diabetes-induced 
pathological processes during late gestation.
Diabetes has profoundly negative effects on pregnancy 
outcome. Diabetic female rats had significantly higher 
number of resorptions and malformations but a lower 
number of viable fetuses, while normal females had no 
malformations and only two resorptions (Table 1). Vari-
ous malformations were observed in fetuses of diabetic 
females; most commonly, growth retardation followed 
by mal-rotations and short mandible as well as head 
mal-development, absence of tail and open neural tube 
(Table 3). Moreover, crown rump length was significantly 
decreased in diabetic embryos regardless of their malfor-
mation status (Table 2). Placental weight was significantly 
higher in diabetic malformed and non-malformed fetuses 
relative to control pregnancies. On the contrary, embryo 
weight was significantly lower in diabetic malformed 
embryos compared to diabetic non-malformed and con-
trol embryos (Table 2).
At GD 17, non-malformed placentae from diabetic 
mothers had significantly lower levels of antioxidant 
vitamins (vitamins C and E), as well as antioxidant trace 
element, Selenium (cofactor of glutathione peroxidase 
and thioredoxin reductase) compared with controls. 
Placentae of malformed fetuses of diabetic mothers had 
even more significant decrease in the levels of vitamin C, 
vitamin E and Selenium compared with non-malformed 
diabetic and controls (Fig. 1). Markers of oxidative stress 
levels and ROS production were higher in placenta of 
diabetic mothers than controls. TBARS levels were sig-
nificantly elevated in placentae of malformed diabetic 
compared to placentae of non-malformed embryos from 
diabetic mothers, and both were significantly elevated 
compared to controls (Fig. 1).
Levels of GSSG were significantly increased in placen-
tae of malformed when compared with non-malformed 
diabetic fetuses, in which GSSG was higher than con-
trols. The ratio of GSH/GSSG is a powerful indicator of 
the ROS production inside the cell and the ability of the 
cell to counteract oxidative stress. Both GSH and GSH/
GSSG ratio were significantly diminished in placentae of 
malformed fetuses of diabetic mothers compared to both 
non-malformed and controls. Furthermore, non-mal-
formed placentae of diabetic mothers had significantly 
reduced levels of GSH and GSH/GSSG ratio compared 
with controls (Fig. 1).
We found significantly elevated levels of NOx in pla-
centae of malformed fetuses of diabetic mothers com-
pared with non-malformed and controls. Moreover, 
NOx were increased in non-malformed diabetic placenta 
compared to controls (Fig. 2). Higher levels of NOx could 
indicate oxidative stress and endothelial dysfunction. 
8-oxo-dG levels were significantly higher in placentae of 
malformed and non-malformed fetuses (Fig. 3).
Placental growth factor 2 (PlGF-2) levels were signifi-
cantly reduced in placentae of fetuses of diabetic mothers 
compared with controls regardless of malformation sta-
tus. Placental levels of sFlt-1 were significantly higher in 
diabetic fetuses placenta regardless of malformation sta-
tus (Fig. 4).
Table 1 Pregnancy outcome of diabetic and control rats
* Significantly different from control rats (P < 0.05) by Fisher’s exact test
Parameters Control Diabetic
No. of litters 9 13
Malformed litters 0 11*
% of malformed litters 0 85
Total no. of implantations 102 123
No. of implantations/litter 11 9
No. of viable embryos 100 98*
No. of resorption 2 25
% of resorption 2 20
No. of malformations 0 40
Table 2 Fetal parameters and  placental weight at  gesta-
tional day 17
* Significantly different from embryos of control mothers (P < 0.05)
# Significantly different from non-malformed embryos of diabetic mothers 
(P < 0.05), by ANOVA







CRL (mm) 12.65 ± 0.21 10.89 ± 0.18* 9.76 ± 0.19*
Embryo weight 
(mg)
288.6 ± 4.21 222.3 ± 4.97* 209.5 ± 4.42*
Placental weight 
(mg)
187.8 ± 3.79 223.1 ± 3.23* 241.5 ± 3.66#
Table 3 The apparent malformation types in  embryos 
of experimental diabetic pregnanacy
Malformation Number of embryos %
Growth retardation 21 52.5
Open neural tube 3 7.5
Maldevelopment of head 5 12.5
Absence of tail 4 10
Malrotation 13 32.5
Short mandible 6 15
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Fig. 1 Impact of maternal diabetes on oxidative stress and antioxidants in placenta. Data are presented as mean ± SD (n = 15). *Statistically signifi-
cant difference from controls, #statistically significant difference from diabetic non-malformed, by ANOVA (P < 0.05)
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Caspase-3 is a critical death protease, indispensable 
for apoptotic chromatin condensation and DNA frag-
mentation. Caspase-3 activity is significantly increased 
in placentae of malformed compared with that of non-
malformed diabetic offspring, which have higher cas-
pase-3 activity compared with controls (Fig.  3). The 
cyclooxygenase isoenzymes, COX-1 and COX-2, cata-
lyze the oxidative cyclization of the central 5 carbons 
within 20 carbon polyunsaturated fatty acid (arachi-
donic acid) to form prostaglandins, thromboxane, and 
levuloglandins. COX-1 is produced constitutively while 
COX-2 is inducible (e.g. by inflammation). COX-1 
enzyme activity did not differ significantly between 
malformed, non-malformed or control fetuses’ placen-
tae. However, inducible COX-2 enzyme activity was 
significantly diminished in malformed compared to 
non-malformed fetuses of diabetic mothers and con-
trols. COX-2 activity was also significantly reduced in 
non-malformed fetuses’ placenta when compared with 
controls (Fig. 5).
Discussion
Diabetes mellitus during pregnancy affects the develop-
mental milieu, jeopardizes the normal fetal development 
and increases the risk of various adult onset morbidities 
(Calkins and Devaskar 2011). We have previously dem-
onstrated that diabetes during pregnancy increases oxi-
dative stress in various fetal tissues including placenta 
(Kamel et al. 2014). However, the effect of maternal dia-
betes on placental inflammation, vascular and oxidative 
stress markers specifically, was not studied thoroughly. 
In this study we demonstrate that oxidative stress is sig-
nificantly elevated in placenta of diabetic pregnancies 
regardless of malformation status of the fetus.
Our results show clearly that diabetic pregnancy pla-
centae exhibit increased oxidative stress. Moreover, the 
intra-cellular antioxidant defense mechanisms, as char-
acterized by Glutathione oxidation parameters, were 
diminished in placentae from diabetic pregnancies. Nor-
mal placentae show a significant increase in oxidative 
stress that is instrumental to their normal development 
(Schafer and Buettner 2001). However, as pregnancy pro-
ceeds, the level of oxidative stress decrease and anti-oxi-
dant levels increase (Basu et al. 2015). This suggests that 
diabetes may disturb normal milieu of placenta through 
increasing oxidative stress.
Fig. 2 Levels of nitric oxide end products NOx (nitrates and nitrites) 
as markers of nitrosative stress in placenta. Data are presented as 
mean ± SD (n = 15). *Statistically significant difference from controls, 
#statistically significant difference from diabetic non-malformed, by 
ANOVA (P < 0.05)
Fig. 3 Levels of 8-oxo dG (DNA oxidation adduct) and cleaved caspase-3 activity as a measure of activated apoptosis in placenta. Data are pre-
sented as mean ± SD (n = 15). *Statistically significant difference from controls, #statistically significant difference from diabetic non-malformed, by 
ANOVA (P < 0.05)
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Other anti-oxidant systems were also diminished in 
placentae of diabetic pregnancies regardless of their 
malformation status. Moreover, anti-oxidant vitamins 
levels in tissues further corroborate the findings indi-
cating increased oxidative stress in placentae of diabetic 
pregnancies. Whether the observed increase in oxida-
tive stress is caused by the diminished anti-oxidants 
levels in placenta or vice versa cannot be elucidated 
form our work. However, it must be noted that normal 
pregnancies exhibit reduced serum levels of vitamin E 
compared to non-pregnant mothers, as pregnancy is a 
physiological condition associated with increased oxi-
dative burden (Yoshioka et al. 1987). Moreover, the level 
of vitamin E in fetal tissues is related to that in corre-
sponding maternal tissues and is amenable to the type 
of diet ingested by the mother (Yoshioka et al. 1987).
The increase in oxidative stress might have caused 
several deleterious effects on various cellular targets. 
TBARS levels were significantly elevated in a similar 
pattern as glutathione compounds, which illustrate the 
increased peroxidation of lipids in the affected placen-
tae. Moreover, markers of DNA oxidation in diabetic 
placentae were also significantly increased indicating 
that the increased oxidative stress was high enough to 
cause such damage. DNA oxidation may hinder normal 
function of cells, which may be explained by the effect 
of these modifications in increasing mutation rate of 
affected cells, specifically transversions (Cooke and 
Evans 2007b).
Furthermore, nitric oxide levels show a similar pat-
tern of elevation as that observed in 8-oxo-dG, which 
may reflect increased protein nitrosylation in placenta. 
Fig. 4 PIGF-2 and sFlt-1/sVEGFR1 expression in placenta indicate vascular and endothelial functions. Data are presented as mean ± SD (n = 15). 
*Statistically significant difference from controls, #statistically significant difference from diabetic non-malformed, by ANOVA (P < 0.05)
Fig. 5 Activity of cyclooxygenases (COX-1 and COX-2) in placenta to assess inflammatory response and prostaglandin production in placenta. 
Data are presented as mean ± SD (n = 15). *Statistically significant difference from controls, #statistically significant difference from diabetic non-
malformed, by ANOVA (P < 0.05)
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Nitrative stress or increased protein nitrosylation is a 
hallmark of complicated pregnancies such as those with 
pre-eclampsia or gestational diabetes, and the nitrosyla-
tion of DNA and proteins hamper the normal function 
of placenta (Lyall et al. 1998; Myatt 2010). Furthermore, 
the increased damage inflicted by the increased oxida-
tive stress was also evident by the increased activity of 
the apoptosis marker Caspase-3 observed in our results. 
Our results hint to the possibility that disturbed placen-
tal milieu may induce fetal programming of adult disease. 
At late gestation, several important physiological changes 
occur that may be affected by the disturbed milieu.
In addition to the parameters of oxidative stress and 
anti-oxidant measured, we also measured the activity 
of various enzymes and growth factors in placenta. Our 
results are in concordance with previous studies that 
demonstrated association of sFlt-1 elevation with diabe-
tes or pre-eclampsia (Salim et al. 2009; Wu et al. 2010). 
Given the known functions of PIGF-2 and sFlt-1, we can 
hypothesize that the observed pattern reflect an abnor-
mality in the fetal or placental vasculature. However, to 
confirm such a hypothesis, thorough analysis of fetal vas-
culature must be conducted.
The downstream effects of the observed increase in 
placental oxidative stress were also observed. The con-
tent of cyclooxygenase isozymes was altered in placentae 
of diabetic malformed and non-malformed fetuses. Our 
results are in concordance with previous work published 
(Al-Matubsi et  al. 2010) were COX-2 was significantly 
reduced in malformed diabetic compared to non-mal-
formed diabetic placentae; however, these measurements 
were conducted on placentae extracted in earlier day of 
gestation. A major discrepancy between both results is 
that in our measurements COX-1 and COX-2 levels were 
comparable, while in Al-Matubsi and colleagues work, 
COX-1 levels were relatively small compared to COX-2. 
In absence of diabetes, oxidative stress induces expres-
sion of COX-2 in murine placenta (Burdon et  al. 2007). 
However, in our results despite increased oxidative stress, 
COX-2 expression was significantly reduced in placenta, 
which may suggest that diabetes might have disrupted 
normal response to oxidative stress.
Our results are in harmony with previous observations 
conducted during different times of gestation. Diabetes in 
pregnancy regardless of malformation status is associated 
with increased oxidative stress and disturbed placental 
function. The exact mechanism by which oxidative stress 
disrupts normal placental function is not known but may 
be a result of a complex menagerie of cellular insults such 
as DNA mutation, protein oxidation and nitrosylation as 
well as apoptosis. Moreover, other conditions related to 
diabetes such as obesity, may contribute to the observed 
placental dysfunction. Although absence of fetal mal-
formation does not rule out placental alteration, we did 
not observe any placental alteration in diabetic embryos 
(malformed and non-malformed). However, to confirm 
or delineate the contribution of these factors, further 
studies should be conducted.
Conclusion
Maternal diabetes is associated with a state of oxidative 
stress, sparseness of various antioxidants and growth 
factors that are critical for endothelial and vascular 
functions, and increased apoptotic activity in placenta. 
Whether theses perturbations are causally related or just 
coincidental with the effects of high glucose on placen-
tal function is still unclear. Further studies are needed to 
confirm and illustrate the molecular mechanisms of these 
abnormalities.
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